Cytokinetics (CYTK) Misses Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $76.84 -0.44%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($0.23), $0.11 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $10.1 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
